The New York Times reports on the interesting information being revealed in the first DePuy ASR hip trial: Separately, a DePuy engineer, Graham Isaac, testified on Thursday that before selling the A.S.R., the company only tested its performance on laboratory equipment at one angle of implantation. Depending on the surgical technique and a patient’s build,
Once again, the FDA arrives late to the party: Jan 17 (Reuters) – The U.S. Food and Drug Administration has issued a proposal calling on companies that make all-metal hip replacements to provide additional information proving they are safe and effective before being allowed to continue selling them. The move follows years of concern within
My Yaz lawyer blog, www.findtherightyazlawyer.com, had gotten a little long in the tooth. So I updated it and added some fresh content for October 2012 regarding Yaz lawsuits and Yaz settlements. Here’s a taste: As of October of 2012, Bayer has settled close to 2,000 Yaz lawsuits for close to $500 million dollars. Bayer has
In early March of 2011, the FDA strengthened the warning label on Topamax (generic name: Topiramate) due to an association between Topamax use and birth defects. Currently, Topamax is most strongly associated with oral birth defects, such as cleft lips and cleft palates. Cleft lips are fairly common birth defects in which the upper lip
Zoloft Birth Defect Lawyers are currently reviewing potential Zoloft lawsuits on behalf of women who took the drug Zoloft (Sertraline) while pregnant and gave birth to a child with certain types of birth defects. “Numerous studies from across the globe have shown that taking antidepressants such as Zoloft increase the risk of giving birth to
Topamax lawyers are heavily advertising on the Internet regarding the link between Topamax and birth defects like cleft palates and cleft lips. To the best of my knowledge, no Topamax attorney has yet filed a Topamax birth defect lawsuit. One of the reasons why I suspect that Topamax litigation will commence so soon after Topamax
On March 4th of 2010, the FDA announced that new data showed that women who take Topamax during pregnancy are at an increased risk of giving birth to a child with a cleft lip or a cleft palate. Topamax and Topiramate (the generic equivalent of Topamax) were approved by the FDA to treat certain types
It wasn’t until March of 2011 that the FDA issued a warning that linked Topamax with cleft palate and cleft lip birth defects. But back in July of 2008, a study linked the drug to those very defects: For the study, researchers examined women who became pregnant while taking topiramate either on its own or along